while several patients celebrate rapid weight loss and improved glucose control, some are less enthusiastic, citing concerns about side effects
Each comparison involves tradeoffs between price, efficacy, side effect profiles, and availability that researchers should evaluate based on their specific protocol requirements and budget constraints
Because of its potential, a solid launch is critical, otherwise the company will need to double down on Victoza, Tresiba, Xultophy and NovoLog/FiAsp to carry them into the next decade
Subscribe to our free weekly newsletter for plain-English updates on the medications, access, and the science, with no spam and no product pitches